Connect with us

General Health

Vision Screeners Market Product Development Survey 2028

Published

on

Press Release

Global Vision Screeners Market: Overview

The demand within the global vision screeners market is growing on account of improvements in ophthalmological testing. The rising incidence of visionary problems in adults and children has played an integral role in market growth. Presence of a stellar industry for diagnosing eye disorders and diseases has also enhanced the growth prospects of the global market. The world health organization (WHO) has released multiple reports on the importance of vision screeners across healthcare facilities. The total revenues within the global vision screener market are expected to multiply in the years to follow.

Eye care clinics have embraced increased level of sophistication in recent times. Doctors and medical practitioners are emphasizing on the need to foster greater resilience in the field of ophthalmology. Furthermore, the changing requirements of the medical fraternity have paved way for the growth of the global vision screeners market. Moreover, opthalmological supervision is a necessary requirement for the geriatric population. This factor, coupled with the increasing investments in medical research, has driven demand within the global market.

Visionary screeners have helped eye care facilities in improving their rating and performance index. Hence, the commercialization of healthcare and medicine has led to widespread installation of vision screeners in hospitals and healthcare centers. There is a large playfield of opportunities for the vendors operating in the global vision screeners market. Moreover, healthcare experts have persuaded government bodies to provide financial incentives for installation of vision screeners across public health facilities.

A syndicate report on the global vision screeners market sheds light on some of the leading drivers of market demand. The vision screeners market can be segmented on the basis of: end-users and region. Based on end-users, children aged 6 to 13 years are frequently subjected to vision screening.

Global Vision Screeners Market: Notable Developments

Stoked improvements in the field of ophthalmology have led to several notable developments in the global market.

  • Spot Vision Screeners, manufactured by Welch Allyn, have come under the spotlight of attention in recent times. The portability and quick-detection of these screeners has generated increased demand for these devices. Moreover, Welch Allyn has set the wheel of innovation to motion, and has invited responses from other vendors.
  • The market vendors are focusing on developing specialized vision screeners for children aged below 13 years. This trend shall create a wide pool of opportunities within the market as the vendors can earn from developing cutting-edge vision screeners for children.

Some of the leading vendors in the global vision screeners market are:

  • Essilor International S.A. (Stereo Optical Company Inc.)
  • OCULUS Surgical, Inc.,
  • Adaptica S.r.l.
  • Honeywell International Inc.
  • Plusoptix Inc. 

Global Vision Screeners Market: Growth Drivers 

  • Quality Healthcare becomes a Priority across Developing Countries

The presence of a stellar industry for healthcare in developed countries has acted as an archetype for developing nations. Governments in emerging nations have increased their investments towards ophthalmic care, and this factor is slated to drive demand within the global vision screeners market. It is expected that the presence of public healthcare clinics in developing regions would drive market demand.

  • Growing Incidence of Eye Strain Disorders

With increasing use of computer and mobile devices, the incidence of eye disorders has increased. This factor has created fresh opportunities for growth within the global vision screeners market. The younger population is encouraged to go for regular vision screening tests which has in turn aided market growth.

Request TOC of the Report for more Industry Insights @ CLICK HERE NOW

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

This post was originally published on Health News Office

General Health

Gene Therapy Market to see huge growth by 2027

Published

on

Press Release

Report Description

A recent market intelligence report that is published by Data Insights Partner on Gene Therapy market makes an offering of in-depth analysis of segments and sub-segments in the regional and international Gene Therapy  market. The research also emphasizes on the impact of restraints, drivers, and macro indicators on the regional and world Gene Therapy market over the short as well as long period of time. A detailed presentation of forecast, trends, and dollar values of international Gene Therapy market is offered. In accordance with the report, the global Gene Therapy market is projected to expand at a CAGR of 30% over the period of forecast.

Market Insight, Drivers, Restraints& Opportunity of the Market:

Gene therapy is a medical procedure which replaces defective genes or introduces new genes n order to prevent or cure genetic disorders. This procedure has become a bench mark in medical industry as there is no requirement of surgery or drugs or other procedure which has side effects on the individuals. Gene therapy was first commercialized in China in 2004 by China based SiBono Gene Tech (product Gendicine).

The global gene therapy market has been expanding due to the rigorous research conducted in the field of genetics. The rising awareness about the capability of cure of several rare genetic diseases by gene therapy is another important driver which leads the global gene therapy market during the forecast period. Gene therapy has capability cure several life threatening diseases such as cancer, cardiac diseases, AIDS, cystic fibrosis, age-related disorders, sickle cell anemia etc. In March 2019, the director of the National Health Institute (NIH), the U.S. announced that the recent clinical trials on the gene therapy for the treatment of sickle cell anemia showed promising result- therefore, increasing prevalence of aforementioned lie threatening diseases would likely to drive the growth of the global gene therapy market during the forecast period.

Request for Report Sample: https://datainsightspartner.com/request-for-sample?ref=8

On the other hand, treatment cost and stringent regulatory conditions etc. may hamper the growth of the global gene therapy market in the upcoming future. The results of Gendicine clinical trials were published in 2003 and the medicine got approval by the China State Food and Drug Administration in the same year. Although approved in China, Gendicine’s use is not very promising outside China. There are several concerns among the researchers about the quality of the clinical trials performed and safety and efficacy of the treatment. However, Gendicine’s equivalent Advexin (company Introgen Therapueitcs) is still waiting for the FDA approval.

 Increasing investment to the gene therapy related research (around 10 Bn was invested in 2015 by private and public organizations), new product developments such as (Zolgensma in 2019), strategic alliance among the key players (such as collaboration between Axovant and Yposkesi) would bring the global gene therapy market an opportunity to propel during the forecast period. In May 2019, Avexis (a Novartis company) has got the FDA approval for Zolgensma for treatment of spinal muscular atrophy for the pediatric patients (less than 2 years of age).

Segment Covered:

This market intelligence report on the global gene therapy market encompasses market segments based on product, application, target user and geography. On the basis of product, the sub-markets is segmented into Yescarta, Kymriah, Strimvelis, Gendicine, Zolgensma and others (Advexin). Based on application, the global gene therapy market has been segregated into large B-Cell lymphoma, Car T Cell therapy, ADA-SCID (adenosine deaminase deficiency), muscular atrophy, head and neck squamus cell carcinoma, others (Crigler-Najjar syndrome). By target user, the global gene therapy market is also classified into adult and pediatric. By Geography, the global gene therapy market has been divided into North America (the U.S., Canada), Latin America (Brazil, Mexico, Argentina and other countries), Europe (Germany, France, the U.K., Spain, Italy, Russia, and other countries), Asia Pacific (India, Japan, China, Australia and New Zealand and other countries), Middle East and Africa (GCC, South Africa, Israel and Other countries).

Profiling of Market Players:

This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as Novartis, Gilead Sciences, Orchard Therapeutics Ltd, SiBiono GeneTech Co, Introgen Therapeutics and among others have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as gene therapy market related investment & spending and developments by major players of the market are tracked in this global report.

Report Highlights:

In-depth analysis of the micro and macro indicators, market trends, and forecasts of demand is offered by this business intelligence report. Furthermore, the report offers a vivid picture of the factors that are steering and restraining the growth of this market across all geographical segments. In addition to that, IGR-Growth Matrix analysis is also provided in the report so as to share insight of the investment areas that new or existing market players can take into consideration. Various analytical tools such as DRO analysis, Porter’s five forces analysis has been used in this report to present a clear picture of the market. The study focuses on the present market trends and provides market forecast from the year 2017-2027. Emerging trends that would shape the market demand in the years to come have been highlighted in this report. A competitive analysis in each of the geographical segments gives an insight into market share of the global players.

Request for Report Analysis: https://datainsightspartner.com/report/gene-therapy-market/8

Salient Features:

Ø This study offers comprehensive yet detailed analysis of the Gene Therapy  market, size of the market (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the period of forecast: 2019 – 2027, taking into account 2017 as the base year

Ø It explains upcoming revenue opportunities across various market segments and attractive matrix of investment proposition for the said market

Ø This market intelligence report also offers pivotal insights about various market opportunities, restraints, drivers, launch of new products, competitive market strategies of leading market players, emerging market trends, and regional outlook

Ø Profiling of key market players in the world Gene Therapy  market is done by taking into account various parameters such as company strategies, distribution strategies, product portfolio, financial performance, key developments, geographical presence, and company overview

Ø Leading market players covered this report comprise names such as. Novartis, Gilead Sciences, Orchard Therapeutics Ltd, SiBiono GeneTech Co, Introgen Therapeutics and among others

Ø The data of this report would allow management authorities and marketers of companies alike to take informed decision when it comes to launch of products, government initiatives, marketing tactics and expansion, and technical up gradation

Ø The world market for Gene Therapy market caters to the needs of various stakeholders pertaining to this industry, namely suppliers, manufacturers, investors, and distributors for Gene Therapy market. The research also caters to the rising needs of consulting and research firms, financial analysts, and new market entrants

Ø Research methodologies that have been adopted for the purpose of this study have been clearly elaborated so as to facilitate better understanding of the reports

Ø Reports have been made based on the guidelines as mandated by General Data Protection Regulation

Ø Ample number of examples and case studies have been taken into consideration before coming to a conclusion

Reasons to buy:

v Identify opportunities and plan strategies by having a strong understanding of the investment opportunities in the Gene Therapy  market

v Identification of key factors driving investment opportunities in the Gene Therapy  market

v Facilitate decision-making based on strong historic and forecast data

v Position yourself to gain the maximum advantage of the industry’s growth potential

v Develop strategies based on the latest regulatory events

v Identify key partners and business development avenues

v Respond to your competitors’ business structure, strategy and prospects

This post was originally published on Health News Office

Continue Reading

Fitness & Exercise

Multiple Sclerosis Treatment Market Vendors Landscape, Recent Trends, Research Discoveries with Opportunities By 2027

Published

on

Press Release

Report Description

A recent market intelligence report that is published by Data Insights Partner on the global multiple sclerosis treatment market makes an offering of in-depth analysis of segments and sub-segments in the regional and international    Multiple Sclerosis Treatment   market. The research also emphasizes on the impact of restraints, drivers, and macro indicators on the regional and global multiple sclerosis treatment market over the short as well as long period of time. A detailed presentation of forecast, trends, and dollar values of global multiple sclerosis treatment market is offered. In accordance with the report, the global multiple sclerosis treatment market is projected to expand at a CAGR of 4% over the period of forecast.

Market Insight, Drivers, Restraints& Opportunity of the Market:

Multiple Sclerosis (MS) is a chronic autoimmune disease which affects the normal communication between brain and the other parts of the body. Particularly, this abnormality damages the membrane of the brain tissues and spinal cords which may cause the patients to show dizziness, unstable gait, fatigue, tremor, partial or complete loss of vision, problems with bladder function etc. However, the symptoms of multiple sclerosis depend on the degree of damage of the brain tissue and spinal cord tissue. However, there is no cure for the patients who are affecting from MS- but the change of lifestyles and medicines help the patients to manage the MS.

Request for Report Sample: https://datainsightspartner.com/request-for-sample?ref=9

The global multiple sclerosis treatment market is primarily driven by the increasing aging population and growing incidence of multiple sclerosis patients across worldwide. Around 3 Million people have been suffering from multiple sclerosis across worldwide- a study estimated that around 0.2% of the total population in the UK suffered from multiple sclerosis in 2018 and this percentage is anticipated to grow by 2% during the forecast period.

On the contrary, the growth of the global multiple sclerosis treatment market may be hampered by low awareness about multiple sclerosis, low diagnosis rate of multiple sclerosis among patients and unavailability of treatments which can completely cure multiple sclerosis among the patients.  In addition, drug recalls due to side effects may restrain the expansion of the global multiple sclerosis treatment market during the forecast period.

However, increasing research and development expenditure by the major players, universities and research hospitals, strategic alliance among the major companies, new product development may bring the global multiple sclerosis treatment market an opportunity to propel in the upcoming period. In March 2019, the USFDA approved Mayzent (siponimod) tables to treat patients with relapsing form of multiple sclerosis.

Segment Covered:

This market intelligence report on the global multiple sclerosis treatment market encompasses market segments based on drug type, distribution channel and geography. On the basis of product, the sub-market is segmented into siponimod, ponesimod, ozanimod, Ofatumumab, Ublituximab and others (including Gocovri etc.) Based on distribution channel, the global   multiple sclerosis treatment market has been segregated into hospital pharmacies, retail pharmacies and drug stores and e-pharmacies. By Geography, the global  Multiple Sclerosis Treatment  market has been divided into North America (the U.S., Canada), Latin America (Brazil, Mexico, Argentina and other countries), Europe (Germany, France, the U.K., Spain, Italy, Russia, and other countries), Asia Pacific (India, Japan, China, Australia and New Zealand and other countries), Middle East and Africa (GCC, South Africa, Israel and Other countries).

Profiling of Market Players:

This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as Novartis, Johnson and Johnson Services, Inc., Celegne, TG Therapeutics, Alkermis Plc., Adamas Pharmaceuticals, Merck KgaA and others have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as multiple sclerosis treatment market related investment & spending and developments by major players of the market are tracked in this global report.

Report Highlights:

In-depth analysis of the micro and macro indicators, market trends, and forecasts of demand is offered by this business intelligence report. Furthermore, the report offers a vivid picture of the factors that are steering and restraining the growth of this market across all geographical segments. In addition to that, IGR-Growth Matrix analysis is also provided in the report so as to share insight of the investment areas that new or existing market players can take into consideration. Various analytical tools such as DRO analysis, Porter’s five forces analysis has been used in this report to present a clear picture of the market. The study focuses on the present market trends and provides market forecast from the year 2017-2027. Emerging trends that would shape the market demand in the years to come have been highlighted in this report. A competitive analysis in each of the geographical segments gives an insight into market share of the global players.

Request for Report Analysis: https://datainsightspartner.com/report/multiple-sclerosis-treatment-market/9

Salient Features:

Ø This study offers comprehensive yet detailed analysis of the  multiple sclerosis treatment market, size of the market (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the period of forecast: 2019 – 2027, taking into account 2018 as the base year

Ø It explains upcoming revenue opportunities across various market segments and attractive matrix of investment proposition for the said market

Ø This market intelligence report also offers pivotal insights about various market opportunities, restraints, drivers, launch of new products, competitive market strategies of leading market players, emerging market trends, and regional outlook

Ø Profiling of key market players in the world    multiple sclerosis treatment   market is done by taking into account various parameters such as company strategies, distribution strategies, product portfolio, financial performance, key developments, geographical presence, and company overview

Ø Leading market players covered this report comprise names such as. Novartis, Johnson and Johnson Services, Inc., Celegne, TG Therapeutics, Alkermis Plc., Adamas Pharmaceuticals, Merck KgaA and among others

Ø The data of this report would allow management authorities and marketers of companies alike to take informed decision when it comes to launch of products, government initiatives, marketing tactics and expansion, and technical up gradation

Ø The world market for multiple sclerosis treatment market caters to the needs of various stakeholders pertaining to this industry, namely suppliers, manufacturers, investors, and distributors for multiple sclerosis treatment market. The research also caters to the rising needs of consulting and research firms, financial analysts, and new market entrants

Ø Research methodologies that have been adopted for the purpose of this study have been clearly elaborated so as to facilitate better understanding of the reports

Ø Reports have been made based on the guidelines as mandated by General Data Protection Regulation

Ø Ample number of examples and case studies have been taken into consideration before coming to a conclusion

Reasons to buy:

v Identify opportunities and plan strategies by having a strong understanding of the investment opportunities in the    Multiple Sclerosis Treatment   market

v Identification of key factors driving investment opportunities in the    Multiple Sclerosis Treatment   market

v Facilitate decision-making based on strong historic and forecast data

v Position yourself to gain the maximum advantage of the industry’s growth potential

v Develop strategies based on the latest regulatory events

v Identify key partners and business development avenues

v Respond to your competitors’ business structure, strategy and prospects

v Identify key strengths and weaknesses of important market participants

This post was originally published on Health News Office

Continue Reading

General Health

Know the Future Opportunities of PEDIATRIC ULTRASOUND Market | Analogic Corporation, Esaote SpA, Fujifilm Corporation, General Electric Company

Published

on

Press Release

The ‘ PEDIATRIC ULTRASOUND market’ research report added by Report Ocean, is an in-depth analysis of the latest trends, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market introduction, PEDIATRIC ULTRASOUND market definition, regional market scope, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, PEDIATRIC ULTRASOUND market size forecast, 100+ market data, Tables, Pie Chart, Graphs and Figures, and many more for business intelligence.

 UPTO 30% OFF ON SINGLE USER PDF: https://www.reportocean.com/industry-verticals/sample-request.php?report_id=26927

 In the PEDIATRIC ULTRASOUND Market, some of the major companies are:

Analogic Corporation
Esaote SpA
Fujifilm Corporation
General Electric Company
Hitachi, Ltd.
Koninklijke Philips N.V.
Mindray Medical International Limited
Samsung Medison Co. Ltd.
Siemens Healthcare
Toshiba Corporation

The report consists of various chapters and company profiling is a major among them. Company profiling garners business intelligence and track key elements of a business, such as:

  • Company Background
  • Product Categories
  • Competitive Landscape
  • Financial Results (Subject to availability)
  • Media Monitoring
  • Customized Section

PEDIATRIC ULTRASOUND Market: Insights

An ultrasound system uses high-pitched sound waves to visualize the internal structures of the body. Ultrasound systems find application in various clinical areas one of which is cardiology. A combination of ultrasound and Doppler imaging is used to study the heart’s anatomy and function in children. This test uses ultrasound waves that create different images of the heart, which the pediatric cardiologist further analyzes, to interpret the physiological condition of the heart. Children of all ages, including fetuses and newborns, to adolescents can undergo this test. Ultrasound devices, increase in the prevalence and incidents rate of cardiac diseases, and increase in the number of ultrasound diagnostic imaging procedures particularly in pediatrics, are some of its major advancements. Moreover, an ultrasound scan is generally preferred for children as there is no threat of exposure to ionizing radiations harming the tender body tissues (with repeated exposure) of infants. Conversely, dearth of skilled and experienced sonographers worldwide is a major factor restraining the market growth. The global pediatric ultrasound market for cardiology was $252 million in 2015 and is projected to reach $332 million by 2022, growing at a CAGR of 4% from 2016 to 2022

The pediatric ultrasound market for cardiology has flourished due to a large number of technological advancements in the industry, increase in the prevalence and incidents rate of congenital and acquired heart diseases (such as cardiomyopathy, rheumatic fever, kawasaki disease, and infective endocarditis) and increase in the number of ultrasound diagnostic imaging procedures particularly in pediatrics. The market has become mature in developed regions. However, the growth in these regions is primarily due to the technological innovations in the ultrasound industry to develop more portable ultrasound devices for point-of-care settings. However, the pediatric ultrasound market for cardiology is growing rapidly in emerging markets such as Asia-Pacific and LAMEA.

Get a Sample Report for more Expert and Official insights: @ https://www.reportocean.com/industry-verticals/sample-request.php?report_id=26927

The Global PEDIATRIC ULTRASOUND Market is segmented into various sub-groups to understand the market scenario in detail, the market segmentation are as follows:

MARKET BY AGE GROUP

Newborns (0-4 weeks)
Infants (4 weeks-1 year)
Toddlers (1-3 years)
Preschoolers (4-6 years)
School-Aged Children (6-13 years)
Adolescents (13-19 years)

Furthermore, the years considered for the study are as follows:

Historical year – 2013-2017

Base year – 2018

Forecast period** – 2019 to 2025 [** unless otherwise stated]

Regional split of the Global PEDIATRIC ULTRASOUND Market research report is as follows:

The market research study offers in-depth regional analysis along with the current market scenarios. The major regions analyzed in the study are:

  • Americas
  • Europe
  • Middle East & Africa
  • Asia Pacific

Key highlights and important features of the Report:

Overview and highlights of product and application segments of the global PEDIATRIC ULTRASOUND Market are provided. Highlights of the segmentation study include price, revenue, sales, sales growth rate, and market share by product.

Explore about Sales data of key players of the global PEDIATRIC ULTRASOUND Market as well as some useful information on their business. It talks about the gross margin, price, revenue, products, and their specifications, type, applications, competitors, manufacturing base, and the main business of key players operating in the PEDIATRIC ULTRASOUND Market.

Explore about gross margin, sales, revenue, production, market share, CAGR, and market size by region.

Describe PEDIATRIC ULTRASOUND Market Findings and Conclusion, Appendix, methodology and data source;

Research Methodology:

The market research was done by adopting various tools under the category of primary and secondary research. For primary research, experts and major sources of information have been interviewed from suppliers’ side and industries, to obtain and verify the data related to the study of the Global PEDIATRIC ULTRASOUND Market. In secondary research methodology, various secondary sources were referred to collect and identify extensive piece of information, such as paid databases, directories and annual reports and databases for commercial study of the Global PEDIATRIC ULTRASOUND Market. Moreover, other secondary sources include studying technical papers, news releases, government websites, product literatures, white papers, and other literatures to research the market in detail.

Browse Premium Research Report with Tables and Figures at @ https://www.reportocean.com/industry-verticals/details?report_id=26927

There are 15 Chapters to display the Global PEDIATRIC ULTRASOUND Market:

Chapter 1, to describe Definition, Specifications and Classification of Global PEDIATRIC ULTRASOUND, Applications of , Market Segment by Regions;
Chapter 2, to analyze the Manufacturing Cost Structure, Raw Material and Suppliers, Manufacturing Process, Industry Chain Structure;
Chapter 3, to display the Technical Data and Manufacturing Plants Analysis of , Capacity and Commercial Production Date, Manufacturing Plants Distribution, Export & Import, R&D Status and Technology Source, Raw Materials Sources Analysis;
Chapter 4, to show the Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis (Company Segment);
Chapter 5 and 6, to show the Regional Market Analysis that includes United States, EU, Japan, China, India & Southeast Asia, Segment Market Analysis (by Type);
Chapter 7 and 8, to explore the Market Analysis by Application Major Manufacturers Analysis;
Chapter 9, Market Trend Analysis, Regional Market Trend, Market Trend by Product Type, Market Trend by Application;
Chapter 10, Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis;
Chapter 11, to analyze the Consumers Analysis of Global PEDIATRIC ULTRASOUND by region, type and application;
Chapter 12, to describe PEDIATRIC ULTRASOUND Research Findings and Conclusion, Appendix, methodology and data source;
Chapter 13, 14 and 15, to describe PEDIATRIC ULTRASOUND sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is “one-stop solution” for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:

Name: Varda

Email: [email protected]

Address: Classic Tower, Rajnagar Extension, Ghaziabad, 201017 – India

Tel: +1 888 212 3539 (US – TOLL FREE)

Website: https://www.reportocean.com/

 

This post was originally published on Health News Office

Continue Reading

Trending